|
1
|
Cruz-Jentoft AJ, Landi F, Schneider SM,
Zúñiga C, Arai H, Boirie Y, Chen LK, Fielding RA, Martin FC, Michel
JP, et al: Prevalence of and interventions for sarcopenia in ageing
adults: A systematic review Report of the International Sarcopenia
Initiative (EWGSOP and IWGS). Age Ageing. 43:748–759.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen LK, Liu LK, Woo J, Assantachai P,
Auyeung TW, Bahyah KS, Chou MY, Chou LY, Hsu PS, Krairit O, et al:
Sarcopenia in Asia: Consensus report of the Asian working group for
sarcopenia. J Am Med Dir Assoc. 15:95–101. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cruz-Jentoft AJ, Baeyens JP, Bauer JM,
Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y,
Schneider SM, et al: Sarcopenia: European consensus on definition
and diagnosis: Report of the European working group on Sarcopenia
in older people. Age Ageing. 39:412–423. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Nishikawa H, Shiraki M, Hiramatsu A,
Moriya K, Hino K and Nishiguchi S: Japan Society of Hepatology
guidelines for sarcopenia in liver disease (1st edition):
Recommendation from the working group for creation of sarcopenia
assessment criteria. Hepatol Res. 46:951–963. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ohashi K, Ishikawa T, Hoshi A, Suzuki M,
Mitobe Y, Yamada E, Abeywickrama HM, Seki N, Koyama C, Aoki H and
Koyama Y: Relationship between sarcopenia and both physical
activity and lifestyle in patients with chronic liver disease. J
Clin Med Res. 10:920–927. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hanai T, Shiraki M, Nishimura K, Ohnishi
S, Imai K, Suetsugu A, Takai K, Shimizu M and Moriwaki H:
Sarcopenia impairs prognosis of patients with liver cirrhosis.
Nutrition. 31:193–199. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Iritani S, Imai K, Takai K, Hanai T, Ideta
T, Miyazaki T, Suetsugu A, Shiraki M and Moriwaki H: Skeletal
muscle depletion is an independent prognostic factor for
hepatocellular carcinoma. J Gastroenterol. 50:323–332.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kim G, Kang SH, Kim MY and Baik SK:
Prognostic value of sarcopenia in patients with liver cirrhosis: A
systematic review and meta-analysis. PLoS One.
12(e0186990)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hamaguchi Y, Kaido T, Okumura S, Kobayashi
A, Hammad A, Tamai Y, Inagaki N and Uemoto S: Proposal for new
diagnostic criteria for low skeletal muscle mass based on computed
tomography imaging in Asian adults. Nutrition. 32:1200–1205.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kaido T, Ogawa K, Fujimoto Y, Ogura Y,
Hata K, Ito T, Tomiyama K, Yagi S, Mori A and Uemoto S: Impact of
sarcopenia on survival in patients undergoing living donor liver
transplantation. Am J Transplant. 13:1549–1556. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fujiwara N, Nakagawa H, Kudo Y, Tateishi
R, Taguri M, Watadani T, Nakagomi R, Kondo M, Nakatsuka T, Minami
T, et al: Sarcopenia, intramuscular fat deposition, and visceral
adiposity independently predict the outcomes of hepatocellular
carcinoma. J Hepatol. 63:131–140. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ohashi K, Ishikawa T, Imai M, Suzuki M,
Hoshii A, Abe H, Koyama F, Nakano T, Ueki A, Noguchi H, et al:
Relationship between pre-sarcopenia and quality of life in patients
with chronic liver disease: A cross-sectional study. Eur J
Gastroenterol Hepatol. 31:1408–1413. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Moriwaki H, Miwa Y, Tajika M, Kato M,
Fukushima H and Shiraki M: Branched-chain amino acids as a protein-
and energy-source in liver cirrhosis. Biochem Biophys Res Commun.
313:405–409. 2004.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ohara M, Ogawa K, Suda G, Kimura M,
Maehara O, Shimazaki T, Suzuki K, Nakamura A, Umemura M, Izumi T,
et al: L-carnitine suppresses loss of skeletal muscle mass in
patients with liver cirrhosis. Hepatol Commun. 2:906–918.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pekala J, Patkowska-Sokoła B, Bodkowski R,
Jamroz D, Nowakowski P, Lochyński S and Librowski T:
L-carnitine-metabolic functions and meaning in humans life. Curr
Drug Metab. 12:667–678. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kendler BS: Carnitine: An overview of its
role in preventive medicine. Prev Med (Baltim). 15:373–390.
1986.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nakanishi H, Kurosaki M, Tsuchiya K,
Nakakuki N, Takada H, Matsuda S, Gondo K, Asano Y, Hattori N,
Tamaki N, et al: L-carnitine reduces muscle cramps in patients with
cirrhosis. Clin Gastroenterol Hepatol. 13:1540–1543.
2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shiraki M, Shimizu M, Moriwaki H, Okita K
and Koike K: Carnitine dynamics and their effects on hyperammonemia
in cirrhotic Japanese patients. Hepatol Res. 47:321–327.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hiramatsu A, Aikata H, Uchikawa S, Ohya K,
Kodama K, Nishida Y, Daijo K, Osawa M, Teraoka Y, Honda F, et al:
Levocarnitine use is associated with improvement in sarcopenia in
patients with liver cirrhosis. Hepatol Commun. 3:348–355.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Clinical practice guidelines for
hepatocellular carcinoma differ between Japan, United States, and
Europe. Liver Cancer 4: 85-95, 2015.
|
|
21
|
Hamaguchi Y, Kaido T, Okumura S, Fujimoto
Y, Ogawa K, Mori A, Hammad A, Tamai Y, Inagaki N and Uemoto S:
Impact of quality as well as quantity of skeletal muscle on
outcomes after liver transplantation. Liver Transpl. 20:1413–1419.
2014.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Johnson PJ, Berhane S, Kagebayashi C,
Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A,
Palmer D, et al: Assessment of liver function in patients with
hepatocellular carcinoma: A new evidence-based approach-the ALBI
grade. J Clin Oncol. 33:550–558. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hiraoka A, Kumada T, Kudo M, Hirooka M,
Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, et
al: Albumin-Bilirubin (ALBI) grade as part of the evidence-based
clinical practice guideline for HCC of the Japan Society of
Hepatology: A comparison with the liver damage and child-pugh
classifications. Liver Cancer. 6:204–215. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Vallet-Pichard A, Mallet V, Nalpas B,
Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H and Pol S:
FIB-4: An inexpensive and accurate marker of fibrosis in HCV
infection. Comparison with liver biopsy and fibrotest. Hepatology.
46:32–36. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono
M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kaneyama K, et al:
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver
disease population. BMC Gastroenterol. 12(2)2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sterling RK, Lissen E, Clumeck N, Sola R,
Correa MC, Montaner J, Sulkowski MS, Torriani FJ, Dieterich DT,
Thomas DL, et al: Development of a simple noninvasive index to
predict significant fibrosis in patients with HIV/HCV coinfection.
Hepatology. 43:1317–1325. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Nishikawa H, Enomoto H, Yoh K, Iwata Y,
Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, et
al: Association between sarcopenia and depression in patients with
chronic liver diseases. J Clin Med. 8(634)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hanai T, Shiraki M, Ohnishi S, Miyazaki T,
Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Moriwaki H and
Shimizu M: Rapid skeletal muscle wasting predicts worse survival in
patients with liver cirrhosis. Hepatol Res. 46:743–751.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Flanagan JL, Simmons PA, Vehige J, Willcox
MD and Garrett Q: Role of carnitine in disease. Nutr Metab (Lond).
7(30)2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sakai Y, Nishikawa H, Enomoto H, Yoh K,
Iwata Y, Hasegawa K, Nakano C, Kishino K, Shimono Y, Takata R, et
al: Effect of L-carnitine in patients with liver cirrhosis on
energy metabolism using indirect calorimetry: A pilot study. J Clin
Med Res. 8:863–869. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Malaguarnera M, Pistone G, Elvira R,
Leotta C, Scarpello L and Liborio R: Effects of L-carnitine in
patients with hepatic encephalopathy. World J Gastroenterol.
11:7197–7202. 2005.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Qiu J, Thapaliya S, Runkana A, Yang Y,
Tsien C, Mohan ML, Narayanan A, Eghtesad B, Mozdzak PE, McDobald C,
et al: Hyperammonemia in cirrhosis induces transcriptional
regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl
Acad Sci USA. 110:18162–18167. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sawicka AK, Hartmane D, Lipinska P,
Wojtowicz E, Lysiak-Szydlowska W and Olek RA: L-carnitine
supplementation in older women. A pilot study on aging skeletal
muscle mass and function. Nutrients. 10(255)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bhanji RA, Moctezuma-Velazquez C,
Duarte-Rojo A, Ebadi M, Ghosh S, Rose C and Montano-Loza AJ:
Myosteatosis and sarcopenia are associated with hepatic
encephalopathy in patients with cirrhosis. Hepatol Int. 12:377–386.
2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hamaguchi Y, Kaido T, Okumura S, Kobayashi
A, Shirai H, Yao S, Yagi S, Kamo N, Okajima H and Uemoto S:
Proposal for new selection criteria considering pre-transplant
muscularity and visceral adiposity in living donor liver
transplantation. J Cachexia Sarcopenia Muscle. 9:246–254.
2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Patel N and Muñoz SJ: Bone disease in
cirrhosis. Clin Liver Dis (Hoboken). 6:96–99. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
38
|
Tilg H, Moschen AR, Kaser A, Pines A and
Dotan I: Gut, inflammation and osteoporosis: Basic and clinical
concepts. Gut. 57:684–694. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Shakeri A, Tabibi H and Hedayati M:
Effects of L-carnitine supplement on serum inflammatory cytokines,
C-reactive protein, lipoprotein (a), and oxidative stress in
hemodialysis patients with Lp (a) hyperlipoproteinemia. Hemodial
Int. 14:498–504. 2010.PubMed/NCBI View Article : Google Scholar
|
